BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 10606246)

  • 21. Regulation of expression of the early growth response gene-1 (EGR-1) in malignant and benign cells of the prostate.
    Mora GR; Olivier KR; Mitchell RF; Jenkins RB; Tindall DJ
    Prostate; 2005 May; 63(2):198-207. PubMed ID: 15486985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma.
    Zhang L; Zhan S; Navid F; Li Q; Choi YH; Kim M; Seth P; Helman LJ
    Oncogene; 1998 Sep; 17(10):1261-70. PubMed ID: 9771969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a teleost insulin-like growth factor II (IGF-II) gene: evidence for promoter CCAAT/enhancer-binding protein (C/EBP) sites, and the presence of hepatic C/EBP.
    Shamblott MJ; Leung S; Greene MW; Chen TT
    Mol Mar Biol Biotechnol; 1998 Sep; 7(3):181-90. PubMed ID: 9701612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression and activity of the immediate-early growth response (Egr-1) gene product during cellular senescence.
    Meyyappan M; Wheaton K; Riabowol KT
    J Cell Physiol; 1999 Apr; 179(1):29-39. PubMed ID: 10082129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1.
    Zhang X; Liu Y
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1216-25. PubMed ID: 12569082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells.
    Xu L; Xie K; Mukaida N; Matsushima K; Fidler IJ
    Cancer Res; 1999 Nov; 59(22):5822-9. PubMed ID: 10582705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1.
    Murphy BJ; Andrews GK; Bittel D; Discher DJ; McCue J; Green CJ; Yanovsky M; Giaccia A; Sutherland RM; Laderoute KR; Webster KA
    Cancer Res; 1999 Mar; 59(6):1315-22. PubMed ID: 10096565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of CD44 induction by IL-1: a critical role for Egr-1.
    Fitzgerald KA; O'Neill LA
    J Immunol; 1999 Apr; 162(8):4920-7. PubMed ID: 10202038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha.
    Liao H; Hyman MC; Lawrence DA; Pinsky DJ
    FASEB J; 2007 Mar; 21(3):935-49. PubMed ID: 17197388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.
    Liu C; Calogero A; Ragona G; Adamson E; Mercola D
    Crit Rev Oncog; 1996; 7(1-2):101-25. PubMed ID: 9109500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
    Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
    Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Construction of human Egr-1 promoter and its response to ionizing radiation in tumor cells].
    Xu XJ; Ding LH; Wang LX; Qin X; Cheng L; Jiang K; Ye QN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):973-5. PubMed ID: 19900359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum response elements mediate protein kinase C dependent transcriptional induction of early growth response gene-1 by arginine vasopressin in rat mesangial cells.
    Rupprecht HD; Sukhatme VP; Rupprecht AP; Sterzel RB; Coleman DL
    J Cell Physiol; 1994 May; 159(2):311-23. PubMed ID: 8163570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
    Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
    Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product.
    Kim SO; Park JG; Lee YI
    Cancer Res; 1996 Aug; 56(16):3831-6. PubMed ID: 8706031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.